European Federation of Pharmaceutical Industries and Associations (EFPIA)

<
>
How to read and use this data card.
LOADING...
1717450
0e0020135cfc4775bb5a4bd0313b120d

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

5,503,206€

Financial year: 01/01/2017 - 01/12/2017

Lobbyists declared: 15.75 FTE (30)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.

10
5
0.75

Lobbyists with EP accreditation: 8

5
1
1
1

Meetings with European Commission: 42

Lobbying costs over the years:

1
5
10
100
1000

European Federation of Pharmaceutical Industries and Associations (EFPIA)

Registration on EU Transparency Register

38526121292-88 (First registered: 04 Mar 2009)

Goals / Remit

EFPIA operates as the representative organisation of the research based pharmaceutical industry in Europe. The aim of the Federation, which has no profit-making purpose, is to promote pharmaceutical discovery and development in Europe and to promote a European regulatory environment, which facilitates innovative medicinal products to the market in order to improve human health worldwide.

In addition, EFPIA pursues a mainly scientific aim, ensuring and promoting the technological and economic development of the pharmaceutical industry in Europe. EFPIA’s activities extend to all matters of common interest to its members. In particular, it aims to foster an environment that encourages pharmaceutical research and development, manufacture in compliance with high quality standards, intellectual property protection and the introduction of regulatory requirements to allow patients rapid access to medicinal products.

EFPIA has developed Guidance for its members and it is available on its website.

Issues

Any health or pharmaceutical policy stemming from the European Institutions such as life sciences strategy, European Semester, Europe 2020 strategy, IMI, HTA policy etc. EFPIA also follows ongoing trade negotiations and legislative files when relevant to the innovative pharmaceutical industry (such as Water Framework Directive, Welfare of animals in scientific testing etc).

Address

Head office:
8 Rue Mil Neuf Cents
Luxembourg L-2157,
Luxembourg

Tel: 32 26262555

Belgium office:
Rue du Trône 108
Brussels 1050,
Belgium

Tel: 32 26262555